Research Article
Multidrug-Resistant and Carbapenemase-Producing Enterobacteriaceae in Addis Ababa, Ethiopia
Table 4
Antibiotic resistance pattern of MDRE at ICL, Addis Ababa, Ethiopia.
| | Isolates () | CRO | CAZ | FEP | CXM | FOX | MER | IMP | ETP | SXT | CIP | GM | AMP | AMC | AN | ATM | TZP | Total () |
| | E. coli | 110 (72.8) | 108 (71.5) | 110 (72.8) | 107 (70.9) | 20 (13.2) | 2 (1.3) | 1 (0.7) | 5 (3.3) | 114 (75.5) | 56 (37.1) | 15 (9.9) | 148 (98.0) | 143 (93.4) | 1 (0.7) | 113 (74.8) | 15 (9.9) | 151 | | K. pneumoniae | 26 (76.5) | 25 (73.5) | 25 (73.5) | 27 (79.4) | 7 (20.6) | 4 (11.8) | 5 (14.7) | 4 (11.8) | 29 (85.3) | 14 (41.2) | 5 (14.7) | NA | 28 (82.4) | 0 (0.0) | 26 (76.5) | 8 (23.5) | 34 | | Enterobacter Spp. | 8 (80.0) | 5 (50.0) | 7 (70.0) | 8 (80.0) | 9 (90.0) | 0 (0.0) | 0 (0.0) | 1 (10.0) | 8 (80.0) | 3 (30.0) | 3 (30.0) | 10 (100.0) | 10 (100) | 0 (0.0) | 8 (80.0) | 2 (20.0) | 10 | | Citrobacter spps. | 2 (22.2) | 2 (22.2) | 1 (11.1) | 4 (44.4) | 4 (44.4) | 0 (0.0) | 2 (22.2) | 0 (0.0) | 5 (55.6) | 2 (22.2) | 0 (0.0) | NA | 9 (100.0) | 0 (0.0) | 5 (55.6) | 1 (11.1) | 9 | | P. mirabilis | 1 (33.3) | 0 (0.0) | 1 (33.3) | 3 (100) | 1 (33.3) | 0 (0.0) | 0 (0.0) | 0 (0.0) | 1 (33.3) | 1 (33.3) | 0 (0.0) | 2 (66.7) | 2 (66.7) | 0 (0.0) | 1 (33.3) | 0 (0.0) | 3 | | Other | 4 (57.1) | 3 (42.9) | 3 (42.9) | 5 (71.4) | 3 (42.9) | 1 (14.9) | 2 (28.6) | 2 (28.6) | 5 (71.4) | 3 (42.9) | 2 (28.6) | 6 (85.7) | 6 (85.7) | 2 (28.6) | 4 (57.1) | 2 (28.6) | 7 | | Total resistance | 150 (70.0) | 143 (66.8) | 146 (68.2) | 154 (71.9) | 44 (20.6) | 7 (3.3) | 10 (4.7) | 12 (5.6) | 162 (75.7) | 79 (36.9) | 25 (11.7) | 166 (77.6) | 198 (92.5) | 3 (1.4) | 157 (73.4) | 28 (13.1) | 214 |
|
|
Note: CRO: ceftriaxone; CAZ: ceftazidime; FEP: cefepime; CXM: cefuroxime; FOX: cefoxitin; MEM: meropenem; IMP: imipenem; SXT: trimethoprim-sulfamethoxazole; CIP: ciprofloxacin; GM: gentamicin; AMP: ampicillin; AMC: amoxicillin-clavulanic acid; AN: amikacin; ATM: aztreonam; TZP: piperacillin/tazobactam; ETP: ertapenem.
|
